Different Manufacturing Techniques of Facial Prostheses

Last updated: March 6, 2025
Sponsor: Cairo University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Indirect Mould Making

Rapid Manufacturing

Direct Mould Making

Clinical Study ID

NCT06864091
1024
  • Ages 20-60
  • All Genders

Study Summary

All participants will undergo 3-dimentional facial scan and the defect site will be scanned using intraoral scanner. the data will be extracted in Standard tessellation Language (STL) and used in virtual prosthesis reconstruction.

  • (Group 1) involves direct printing of the final prosthesis using biocompatible rubber-like printable soft resin.

  • Group 2, involves direct manufacturing of the negative mold, it will be virtually designed based on an inverted STL file of prosthesis prototype/ pattern.

  • Group 3, involves fabrication of the negative mold indirectly by printing the prosthesis prototype from resin and then duplicating it into wax and a conventional stone mold will be fabricated.

  • The negative molds of both groups 2&3 will be used in packing medical grade silicone (to cast the final prosthesis.

  • All final prostheses will be colored and characterized to match the surrounding anatomy.

  • Esthetic outcomes will be assessed using VAS scale by answering operator and patient related questionnaires. The patient related questionnaire will be translated to the patients and responses will be recorded. For each patient, a score will be given from 1-5.

  • Prosthesis accuracy will be assessed using Medit software, comparing the scan of the final prosthesis to the STL of the prosthesis design and the root mean square (RMS) will be recorded.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients with cartilaginous facial defects, i.e: auricular and nasal defects.

  2. Patients between 20-60 years old.

  3. Post traumatic patients with facial defects.

  4. Patients with congenital facial defects.

  5. Patients with failed facial surgical construction.

  6. Compliant and cooperative patients.

Exclusion

Exclusion Criteria:

1 - Patients having risk of tumor recurrence in the defect area. 2- Patients undergoing radiotherapy or chemotherapy treatment. 3- Patients with any debilitating disease. 4- Patients with any type of psychosomatic disorder. 5- Patients with allergy to any of the materials used.

Study Design

Total Participants: 5
Treatment Group(s): 3
Primary Treatment: Indirect Mould Making
Phase:
Study Start date:
October 01, 2024
Estimated Completion Date:
September 30, 2025

Connect with a study center

  • Cairo University

    Cairo,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.